Gina Chapman - Net Worth and Insider Trading

Gina Chapman Net Worth

The estimated net worth of Gina Chapman is at least $2 Million dollars as of 2024-11-13. Gina Chapman is the President & CEO of Cargo Therapeutics Inc and owns about 103,905 shares of Cargo Therapeutics Inc (CRGX) stock worth over $2 Million. Details can be seen in Gina Chapman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gina Chapman has not made any transactions after 2024-09-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gina Chapman

To

Gina Chapman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gina Chapman owns 1 companies in total, including Entrada Therapeutics Inc (TRDA) .

Click here to see the complete history of Gina Chapman’s form 4 insider trades.

Insider Ownership Summary of Gina Chapman

Ticker Comapny Transaction Date Type of Owner
TRDA Entrada Therapeutics Inc 2023-09-01 director

Gina Chapman Latest Holdings Summary

Gina Chapman currently owns a total of 1 stock. Gina Chapman owns 103,905 shares of Cargo Therapeutics Inc (CRGX) as of September 19, 2024, with a value of $2 Million.

Latest Holdings of Gina Chapman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRGX Cargo Therapeutics Inc 2024-09-19 103,905 21.14 2,196,552

Holding Weightings of Gina Chapman


Gina Chapman Form 4 Trading Tracker

According to the SEC Form 4 filings, Gina Chapman has made a total of 1 transactions in Cargo Therapeutics Inc (CRGX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Cargo Therapeutics Inc is the sale of 10,141 shares on September 19, 2024, which brought Gina Chapman around $254,235.

Insider Trading History of Gina Chapman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gina Chapman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gina Chapman Ownership Network

Ownership Network List of Gina Chapman

No Data

Ownership Network Relation of Gina Chapman

Insider Network Chart

Gina Chapman Owned Company Details

What does Entrada Therapeutics Inc do?

Who are the key executives at Entrada Therapeutics Inc?

Gina Chapman is the director of Entrada Therapeutics Inc. Other key executives at Entrada Therapeutics Inc include Chief Scientific Officer Natarajan Sethuraman , Chief Operating Officer Nathan J Dowden , and Chief Financial Officer Kory James Wentworth .

Entrada Therapeutics Inc (TRDA) Insider Trades Summary

Over the past 18 months, Gina Chapman made no insider transaction in Entrada Therapeutics Inc (TRDA). Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 12,900 shares made by Dipal Doshi , a net sale of 56,124 shares made by Nathan J Dowden , and a net sale of 49,989 shares made by Kory James Wentworth .

In summary, during the past 3 months, insiders sold 55,503 shares of Entrada Therapeutics Inc (TRDA) in total and bought 0 shares, with a net sale of 55,503 shares. During the past 18 months, 206,772 shares of Entrada Therapeutics Inc (TRDA) were sold and 45,368 shares were bought by its insiders, resulting in a net sale of 161,404 shares.

Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Entrada Therapeutics Inc Insider Transactions

No Available Data

Gina Chapman Mailing Address

Above is the net worth, insider trading, and ownership report for Gina Chapman. You might contact Gina Chapman via mailing address: C/o Cargo Therapeutics, Inc., 1900 Alameda De Las Pulgas, Suite 350, San Mateo Ca 94403.